SFU
DXCM icon

Stonehage Fleming (UK)’s DexCom DXCM Stock Holding History

Stonehage Fleming (UK)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,064
Closed -$42K – 210
2014
Q4 		$42K Buy
3,064
+964
+46% +$11.8K 0.02% 175
2014
Q3 		$21K Buy
2,100
+236
+13% +$2.41K 0.01% 245
2014
Q2 		$18K Sell
1,864
-3,280
-64% -$29.1K 0.01% 247
2014
Q1 		$53K Sell
5,144
-3,488
-40% -$36.1K 0.02% 244
2013
Q4 		$76K Buy
+8,632
New +$68.3K 0.03% 181

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Stonehage Fleming (UK)'s DXCM Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of DexCom (DXCM) in Q1 2015, closing a stake of 3,064 shares — an estimated $42K sold.

Stonehage Fleming (UK) first reported a position in DXCM in Q4 2013 and held it in 5 quarters. The position peaked at $76K in Q4 2013. 245 funds tracked by Wall St. Rank hold DXCM as of Q1 2015.

  • Stonehage Fleming (UK) reported no remaining DexCom position as of Q1 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 3,064 DexCom shares in Q1 2015, an estimated $42K.
  • Stonehage Fleming (UK) first reported a position in DexCom in Q4 2013 and held it in 5 quarters.
  • Stonehage Fleming (UK)'s DexCom position peaked at $76K in Q4 2013.
  • 245 funds tracked by Wall St. Rank held DexCom as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.